Switching to another antithrombotic regimen after an ischemic stroke in patients already receiving aspirin does not reduce the risk of recurrence.
GIM/FP/GP:Formula: see text Neurology:Formula: see text Hematology:Formula: see text.
Building similarity graph...
Analyzing shared references across papers
Loading...
Hajeera Shaik
Dinesh Jillella
Annals of Internal Medicine
Grady Memorial Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Shaik et al. (Mon,) reported a other. Switching to another antithrombotic regimen after an ischemic stroke in patients already receiving aspirin does not reduce the risk of recurrence.
www.synapsesocial.com/papers/69d892d16c1944d70ce040ec — DOI: https://doi.org/10.7326/annals-26-00772-jc
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: